BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 20297912)

  • 1. Extracorporeal photopheresis.
    Treen N
    J Vis Commun Med; 2010 Mar; 33(1):31-3. PubMed ID: 20297912
    [No Abstract]   [Full Text] [Related]  

  • 2. A case of poikiloderma vasculare atrophicans, a rare variant of cutaneous T-cell lymphoma, responding to extracorporeal photopheresis.
    Kreuter A; Hoffmamm K; Altmeyer P
    J Am Acad Dermatol; 2005 Apr; 52(4):706-8. PubMed ID: 15793532
    [No Abstract]   [Full Text] [Related]  

  • 3. The therapeutic potential of extracorporeal photopheresis.
    Girardi M
    Clin Adv Hematol Oncol; 2006 May; 4(5):349-50. PubMed ID: 16728944
    [No Abstract]   [Full Text] [Related]  

  • 4. Small-scale extracorporeal photopheresis for the treatment of cutaneous T-cell lymphoma: a report of 3 cases.
    Schreiner T; Gaczkowski A; Scharffetter-Kochanek K; Borberg H
    Transfus Apher Sci; 2005 Apr; 32(2):197-203. PubMed ID: 15784454
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Measuring HRQOL in patients with cutaneous T-cell lymphoma undergoing therapy with oral bexarotene and extracorporeal photopheresis.
    Demierre MF; Ferzli P; Miller D
    Arch Dermatol; 2007 May; 143(5):659-61. PubMed ID: 17515522
    [No Abstract]   [Full Text] [Related]  

  • 6. [Extracorporeal photopheresis in dermatology].
    Pérez-Carmona L; Harto-Castaño A; Díez-Recio E; Jaén-Olasolo P
    Actas Dermosifiliogr; 2009; 100(6):459-71. PubMed ID: 19709550
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Photopheresis].
    Ortiz-Romero PL
    Actas Dermosifiliogr; 2009; 100(6):443-4. PubMed ID: 19709547
    [No Abstract]   [Full Text] [Related]  

  • 8. Extracorporeal photopheresis: Lighting the way to immunomodulation.
    Babic AM
    Am J Hematol; 2008 Jul; 83(7):589-91. PubMed ID: 18335565
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Extracorporeal photopheresis: a review.
    Oliven A; Shechter Y
    Blood Rev; 2001 Jun; 15(2):103-8. PubMed ID: 11409910
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Extracorporeal photopheresis: the Hellenic experience.
    Dervenoulas J; Tsirigotis P
    Transfus Apher Sci; 2012 Apr; 46(2):169. PubMed ID: 22361574
    [No Abstract]   [Full Text] [Related]  

  • 11. Safety of a new, single, integrated, closed photopheresis system in patients with cutaneous T-cell lymphoma.
    Bisaccia E; Vonderheid EC; Geskin L
    Br J Dermatol; 2009 Jul; 161(1):167-9. PubMed ID: 19298276
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Monitoring the decrease of circulating malignant T cells in cutaneous T-cell lymphoma during photopheresis and interferon therapy.
    Ferenczi K; Yawalkar N; Jones D; Kupper TS
    Arch Dermatol; 2003 Jul; 139(7):909-13. PubMed ID: 12873887
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Treatment of cutaneous T-cell lymphoma: an update.
    Young JW
    J Am Osteopath Assoc; 1993 May; 93(5):591-8, 603. PubMed ID: 8314721
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The North American experience with photopheresis.
    Fraser-Andrews EA; Whittaker SJ; Russell-Jones R
    Ther Apher; 1999 Nov; 3(4):347-8. PubMed ID: 10608733
    [No Abstract]   [Full Text] [Related]  

  • 15. Extracorporeal photochemoimmunotherapy in cutaneous T-cell lymphoma.
    Knobler R; Jantschitsch C
    Transfus Apher Sci; 2003 Feb; 28(1):81-9. PubMed ID: 12620272
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Clinical and flow cytometry outcome of improved photopheresis methods in dermatologic patients].
    Ullrich H; Stolz W; Barlage S; Lackner KJ; Rothe G; Schmitz G
    Beitr Infusionsther Transfusionsmed; 1997; 34():256-64. PubMed ID: 9417345
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Erythrodermic CTCL: a case study of treatment with extracorporeal photopheresis.
    McCann SA; Smith SG
    Dermatol Nurs; 2000 Apr; 12(2):103-8, 111-2. PubMed ID: 11271057
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Aggressive squamous cell carcinomas in patients treated with extracorporeal photopheresis for cutaneous T-cell lymphoma.
    Nehal KS; Green KB; Lim HW
    Arch Dermatol; 1995 Oct; 131(10):1211-2. PubMed ID: 7574848
    [No Abstract]   [Full Text] [Related]  

  • 19. Evidence is lacking for a synergistic or additive effect of combination extracorporeal photopheresis with interferon alfa for cutaneous T-cell lymphoma.
    Zackheim HS
    J Am Acad Dermatol; 2000 Jun; 42(6):1087-8. PubMed ID: 10827420
    [No Abstract]   [Full Text] [Related]  

  • 20. Anaphylaxis following administration of extracorporeal photopheresis for cutaneous T cell lymphoma.
    Tran J; Morris L; Vu A; Reddy S; Duvic M
    Dermatol Online J; 2020 Sep; 26(9):. PubMed ID: 33054950
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.